Abstract
Background: A study was undertaken to evaluate Chlamydia pneumoniae chronic infection, other respiratory infections, and functional impairment in patients with chronic bronchitis (stage 1) and to examine chronic C pneumoniae infection, rate of acute exacerbations of chronic bronchitis, and rate of C pneumoniae eradication following antibiotic treatment (stage 2).
Methods: In the stage 1 study respiratory specimens from 42 patients with steady state chronic bronchitis were analysed for Gram staining, sputum culture, and C pneumoniae DNA detection by nested touchdown polymerase chain reaction (PCR). On the basis of the results of stage 1, a second population of 141 consecutive patients with steady state mild to moderate chronic bronchitis (FEV1 ≥50% predicted) was studied. On admission, at regular intervals, and at exacerbation all patients underwent serological testing for C pneumoniae (microimmunofluorescence) and a nested touchdown PCR to detect C pneumoniae DNA was performed on peripheral blood mononuclear cells (PBMCs). Patients were assessed over a 12 month period. Information regarding the previous 12 months was taken from medical records.
Results: Chronic colonisation of the sputum with C pneumoniae was significantly associated with lower FEV1 and greater airway bacterial colonisation. On admission to the stage 2 study, 80 patients were PCR negative and 61 were PCR positive. Over the 2 years a mean (SD) of 1.43 (1.32) acute exacerbations occurred in PCR negative patients and 2.03 (1.21) in PCR positive patients (p<0.01). During the 12 month follow up period 34 PCR positive patients had acute exacerbations and were treated with azithromycin for 6 weeks. Serological evidence of acute C pneumoniae reinfection/reactivation was found in two of the 34 patients. The rate of C pneumoniae DNA clearance from blood following treatment was 29% at follow up.
Conclusion: Chronic colonisation with C pneumoniae is associated with a higher rate of exacerbations of chronic bronchitis. Long term treatment is required to obtain clearance of the organism from the blood.
Full Text
The Full Text of this article is available as a PDF (137.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anthonisen N. R., Manfreda J., Warren C. P., Hershfield E. S., Harding G. K., Nelson N. A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987 Feb;106(2):196–204. doi: 10.7326/0003-4819-106-2-196. [DOI] [PubMed] [Google Scholar]
- Apfalter P., Blasi F., Boman J., Gaydos C. A., Kundi M., Maass M., Makristathis A., Meijer A., Nadrchal R., Persson K. Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol. 2001 Feb;39(2):519–524. doi: 10.1128/JCM.39.2.519-524.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barnes P. J., Adcock I. M. Transcription factors and asthma. Eur Respir J. 1998 Jul;12(1):221–234. doi: 10.1183/09031936.98.12010221. [DOI] [PubMed] [Google Scholar]
- Blasi F., Boman J., Esposito G., Melissano G., Chiesa R., Cosentini R., Tarsia P., Tshomba Y., Betti M., Alessi M. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis. 1999 Dec;180(6):2074–2076. doi: 10.1086/315126. [DOI] [PubMed] [Google Scholar]
- Blasi F., Legnani D., Lombardo V. M., Negretto G. G., Magliano E., Pozzoli R., Chiodo F., Fasoli A., Allegra L. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J. 1993 Jan;6(1):19–22. [PubMed] [Google Scholar]
- Bureau F., Bonizzi G., Kirschvink N., Delhalle S., Desmecht D., Merville M. P., Bours V., Lekeux P. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1314–1321. doi: 10.1164/ajrccm.161.4.9907010. [DOI] [PubMed] [Google Scholar]
- Dechend R., Maass M., Gieffers J., Dietz R., Scheidereit C., Leutz A., Gulba D. C. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation. 1999 Sep 28;100(13):1369–1373. doi: 10.1161/01.cir.100.13.1369. [DOI] [PubMed] [Google Scholar]
- Dowell S. F., Peeling R. W., Boman J., Carlone G. M., Fields B. S., Guarner J., Hammerschlag M. R., Jackson L. A., Kuo C. C., Maass M. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis. 2001 Jul 20;33(4):492–503. doi: 10.1086/322632. [DOI] [PubMed] [Google Scholar]
- Esposito G., Blasi F., Allegra L., Chiesa R., Melissano G., Cosentini R., Tarsia P., Dordoni L., Cantoni C., Arosio C. Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann Vasc Surg. 1999 Jul;13(4):421–425. doi: 10.1007/s100169900277. [DOI] [PubMed] [Google Scholar]
- Finlay G. A., O'Driscoll L. R., Russell K. J., D'Arcy E. M., Masterson J. B., FitzGerald M. X., O'Connor C. M. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med. 1997 Jul;156(1):240–247. doi: 10.1164/ajrccm.156.1.9612018. [DOI] [PubMed] [Google Scholar]
- Finlay G. A., Russell K. J., McMahon K. J., D'arcy E. M., Masterson J. B., FitzGerald M. X., O'Connor C. M. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax. 1997 Jun;52(6):502–506. doi: 10.1136/thx.52.6.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gieffers J., Füllgraf H., Jahn J., Klinger M., Dalhoff K., Katus H. A., Solbach W., Maass M. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation. 2001 Jan 23;103(3):351–356. doi: 10.1161/01.cir.103.3.351. [DOI] [PubMed] [Google Scholar]
- Kaukoranta-Tolvanen S. S., Teppo A. M., Laitinen K., Saikku P., Linnavuori K., Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog. 1996 Sep;21(3):215–221. doi: 10.1006/mpat.1996.0056. [DOI] [PubMed] [Google Scholar]
- Kol A., Sukhova G. K., Lichtman A. H., Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation. 1998 Jul 28;98(4):300–307. doi: 10.1161/01.cir.98.4.300. [DOI] [PubMed] [Google Scholar]
- Libby P., Sukhova G., Lee R. T., Galis Z. S. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol. 1995;25 (Suppl 2):S9–12. doi: 10.1097/00005344-199500252-00003. [DOI] [PubMed] [Google Scholar]
- Marrie T. J. Chlamydia pneumoniae. Thorax. 1993 Jan;48(1):1–4. doi: 10.1136/thx.48.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peeling R. W., Wang S. P., Grayston J. T., Blasi F., Boman J., Clad A., Freidank H., Gaydos C. A., Gnarpe J., Hagiwara T. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis. 2000 Jun;181 (Suppl 3):S426–S429. doi: 10.1086/315603. [DOI] [PubMed] [Google Scholar]
- Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect. 1992 Jul;25 (Suppl 1):27–34. doi: 10.1016/0163-4453(92)91913-v. [DOI] [PubMed] [Google Scholar]
- Shemer-Avni Y., Lieberman D. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis. 1995 May;171(5):1274–1278. doi: 10.1093/infdis/171.5.1274. [DOI] [PubMed] [Google Scholar]
- Strachan D. P., Carrington D., Mendall M., Butland B. K., Yarnell J. W., Elwood P. Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):493–497. doi: 10.1164/ajrccm.161.2.9904055. [DOI] [PubMed] [Google Scholar]
- Theegarten D., Mogilevski G., Anhenn O., Stamatis G., Jaeschock R., Morgenroth K. The role of chlamydia in the pathogenesis of pulmonary emphysema. Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis. Virchows Arch. 2000 Aug;437(2):190–193. doi: 10.1007/s004280000242. [DOI] [PubMed] [Google Scholar]
- Tong C. Y., Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol. 1993 Apr;46(4):313–317. doi: 10.1136/jcp.46.4.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Von Hertzen L., Alakärppä H., Koskinen R., Liippo K., Surcel H. M., Leinonen M., Saikku P. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect. 1997 Apr;118(2):155–164. doi: 10.1017/s095026889600725x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu L., Skinner S. J., Lambie N., Vuletic J. C., Blasi F., Black P. N. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1148–1151. doi: 10.1164/ajrccm.162.3.9912134. [DOI] [PubMed] [Google Scholar]
- von Hertzen L. C. Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease. Ann Med. 1998 Feb;30(1):27–37. doi: 10.3109/07853899808999382. [DOI] [PubMed] [Google Scholar]
- von Hertzen L., Isoaho R., Leinonen M., Koskinen R., Laippala P., Töyrylä M., Kivelä S. L., Saikku P. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol. 1996 Jun;25(3):658–664. doi: 10.1093/ije/25.3.658. [DOI] [PubMed] [Google Scholar]